Literature DB >> 36204020

Small Bowel Obstruction as a Result of Inflammatory Pseudotumor.

Mohamed Ahmed1, Yusef J Buti2, Asef Bawahab3, Hannah Ghaly4, Ramsey Elsayed5.   

Abstract

Inflammatory pseudotumor is a rare benign neoplasm that has been described in nearly the entire body and is often mistaken for malignancy. The exact etiology remains unknown. We present a case of small bowel obstruction secondary to an inflammatory pseudotumor. The patient's symptoms and radiological findings were very concerning for underlying malignancy. En-block resection was recommended to prevent a recurrence. We aim to shed light on this rare cause of small bowel obstruction.
Copyright © 2022, Ahmed et al.

Entities:  

Keywords:  chronic abdominal pain; inflammatory pseudotumor; small bowel mesentery mass; small bowel obstruction; unintentional weight loss

Year:  2022        PMID: 36204020      PMCID: PMC9527131          DOI: 10.7759/cureus.28707

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Inflammatory pseudotumor is a benign neoplasm that clinically and radiologically mimics malignant tumors. The exact etiology remains unknown. It is presumed to occur secondary to infection, trauma, or surgery. The entire body can be affected, and it has a preference for children and young adults [1]. The differential diagnosis includes teratoma, liposarcoma, and lymphoma. The location of the tumor dictates the clinical presentation. Patients present with nonspecific symptoms, including fever, weight loss, abdominal pain, or a palpable abdominal mass, and nonspecific laboratory findings such as iron deficiency anemia [2]. Surgeons who face such a clinical dilemma with an inability to rule out malignancy should perform an en-block resection which is the recommended therapy for inflammatory pseudotumor in addition to long-term follow-up [3].

Case presentation

A 53-year-old female presented to our emergency room with generalized periumbilical pain associated with nausea and vomiting. Her condition started two years prior with intermittent similar but less severe symptoms which were sometimes associated with diarrhea. Laboratory findings were within normal limits: sodium 136 mmol/L, potassium 3.9 mmol/L, creatinine 0.8 mg/dL, bilirubin 0.4 mg/dl, aspartate transaminase 74 U/L, alanine transaminase 16U/L, white blood cell count 9.3 K/µL, and hemoglobin 12.5 g/dL. Computerized tomography of the abdomen and pelvis revealed a high-grade small bowel obstruction in association with a heterogeneously enhancing lobular mass. The mass was partially encasing the small intestinal transition point and measured 42 × 65 mm, which was consistent with a neoplastic process, most likely small bowel lymphoma. A carcinoid tumor was also a possibility given her intermittent diarrhea symptoms (Figures 1, 2).
Figure 1

Computerized tomography of the abdomen and pelvis.

Heterogeneously enhancing mass (red arrow).

Figure 2

Computerized tomography of the abdomen and pelvis.

Consistent with small bowel obstruction and significantly dilated small bowel (red arrow).

Computerized tomography of the abdomen and pelvis.

Heterogeneously enhancing mass (red arrow). Consistent with small bowel obstruction and significantly dilated small bowel (red arrow). The patient was taken to the operating room, and laparotomy revealed a mass covered by two small bowel loops and containing an abnormal-looking appendix. En-block resection of the mass, appendix, and the two attached small bowel loops as well as side-to-side small bowel anastomosis was performed. Pathology was consistent with inflammatory changes, and peri-appendicitis with no malignancy was identified (Figures 3, 4).
Figure 3

Small bowel histopathology.

Areas of hemorrhage, fibrosis, inflammatory cells, and no malignancy.

Figure 4

Cross-section of the appendix.

Peri-appendiceal acute inflammation, without any malignancy.

Small bowel histopathology.

Areas of hemorrhage, fibrosis, inflammatory cells, and no malignancy.

Cross-section of the appendix.

Peri-appendiceal acute inflammation, without any malignancy. The patient did well and was discharged from the hospital on postoperative day three.

Discussion

In 1953, inflammatory pseudotumor was first described in a patient after right hepatic lobectomy [4]. The etiology remains unknown and is presumed to occur secondary to infections such as Mycobacterium, Epstein-Barr virus, cytomegalovirus, actinomycetes, Nocardia, or an autoimmune reaction [5]. Electron microscopy and molecular analysis by polymerase chain amplification identified intracellular bacilliform organisms and were proposed as the cause [6]. Inflammatory pseudotumor of the liver has been reported in association with intra-abdominal infection sources with bacteria/Actinomyces, with bacteria noted in hepatic tissue sections and biopsy culture [7]. Mycobacterium tuberculosis of the female genital tract has been reported as a cause of inflammatory pseudotumor with clinical, radiological, and laboratory findings (elevated cancer antigen-125 level) mimicking ovarian malignancy [8]. It also has been described after surgery and trauma, which were not the cause in our patient [9]. Although the lungs and orbit are most commonly involved, it has been reported in the liver, pancreas, mesentery, retroperitoneum, diaphragm, bladder, kidney, adrenal gland, esophagus, stomach, small intestine, colon, appendix, and Meckel’s diverticulum [10,11]. Morphologically, it is characterized by a mixture of myofibroblasts, fibroblasts, lymphocytes, and plasma cells in proportions varying from one microscopic field to another and from one tumor to another. Histologically, it contains cells associated with both acute and chronic inflammation, including lymphocytes and plasma cells, myofibroblastic spindle cells, and collagen [12]. Radiological findings are variable on computerized tomography; the mass may be heterogeneous, homogeneous, and with no enhancement [13]. The tumor displays low intensity on T1-weighted images and hyperintensity on T2-weighted images on magnetic resonance imaging due to delayed enhancement secondary to fibrosis within the mass [14]. Spontaneous regression of a hepatic pseudotumor has been reported [15]. High-dose corticosteroid treatment has been used in lung cases where surgical resection was inadvisable, such as for multiple or bilateral lesions and when recurrence occurs following the initial surgical intervention [16]. The recurrence rate was reported to be 41% in orbital inflammatory pseudotumors, with the male gender and severe proptosis associated with a higher recurrence [17]. Adjuvant therapies consisting of cisplatin, doxorubicin, methotrexate, and radiation therapy have been used without great success [18]. Treatment of abdominal inflammatory pseudotumor is complete surgical resection with long-term follow-up [19].

Conclusions

Inflammatory pseudotumor is a benign idiopathic inflammatory process with unknown etiology. It is misdiagnosed as an infectious or neoplastic process. It has been found and reported in almost every organ system. Clinical presentation is variable with nonspecific symptoms and symptoms related to the affected organ. Surgical en-block resection when feasible is recommended to obtain a histological diagnosis and minimize recurrence.
  19 in total

1.  Spontaneous regression of an inflammatory pseudotumor of the liver presenting as an obstructing malignant biliary tumor.

Authors:  S Lévy; A Sauvanet; M D Diebold; C Marcus; N Da Costa; G Thiéfin
Journal:  Gastrointest Endosc       Date:  2001-03       Impact factor: 9.427

Review 2.  Inflammatory pseudotumor: the great mimicker.

Authors:  Madhavi Patnana; Alexander B Sevrukov; Khaled M Elsayes; Chitra Viswanathan; Meghan Lubner; Christine O Menias
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

3.  Successful Treatment of Recurrent Inflammatory Pseudotumor With High-dose Prednisone.

Authors:  Margaret McCarthy; Eric Anderson; Pedro DeBrito
Journal:  J Bronchology Interv Pulmonol       Date:  2018-10

4.  Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience.

Authors:  B M Sanders; K W West; C Gingalewski; S Engum; M Davis; J L Grosfeld
Journal:  J Pediatr Surg       Date:  2001-01       Impact factor: 2.545

5.  The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding.

Authors:  L P Dehner
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

Review 6.  Inflammatory pseudotumor of the liver associated with extrahepatic infection.

Authors:  J E White; C W Chase; J E Kelley; W B Brock; M O Clark
Journal:  South Med J       Date:  1997-01       Impact factor: 0.954

7.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

8.  Inflammatory pseudotumor of the liver in association with a gastrointestinal stromal tumor: a case report.

Authors:  Oswens-S Lo; Ronnie-T Poon; Chi-Ming Lam; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 9.  Inflammatory myofibroblastic tumor presenting as a pancreatic mass: a case report and review of the literature.

Authors:  Surakit Pungpapong; Xochi J Geiger; Massimo Raimondo
Journal:  JOP       Date:  2004-09-10

10.  [Pseudo tumor pelvi-peritoneal tuberculosis: report of four cases].

Authors:  Hanane Saadi; Nissrine Mamouni; Sanaa Errarhay; Chahrazed Bouchikhi; Abdelaziz Banani; Hicham Ammor; Nadia Sqalli; Siham Tizniti; Karim Benmajdoube; Khalid Maazaze; Hind Fatmi; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.